Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Rhea-AI Summary
Talphera (Nasdaq: TLPH), a specialty pharmaceutical company, has announced its participation in the 2024 Maxim Healthcare Virtual Summit. The company's management will engage in a fireside chat and be available for one-on-one meetings with registered investors during the event, which is scheduled for October 15-17, 2024.
Key details of Talphera's participation include:
- Event: 2024 Maxim Healthcare Virtual Summit
- Date: October 16, 2024
- Time: 3:00 PM ET / 12:00 Noon PT
Talphera focuses on developing and commercializing innovative therapies for use in medically supervised settings. Investors and interested parties can access the fireside chat through the provided webcast link.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, TLPH declined 2.57%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Event: 2024 Maxim Healthcare Virtual Summit
Date: October 16, 2024
Time: 3:00 PM ET / 12:00 Noon PT
Webcast link: 2024 Maxim Healthcare Virtual Summit
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the
This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-participate-in-fireside-chat-at-the-2024-maxim-healthcare-virtual-summit-302270671.html
SOURCE Talphera, Inc.
